UPDATE : Friday, June 5, 2020
Meditoxin’s future uncertain, even as final verdict nears by Jeong Sae-im 2020-05-25 14:38
Fall in new Covid-19 cases hampers developing treatment by Jeong Sae-im 2020-05-22 17:31
Korean pharma’s Q1 performance not affected by Covid-19 by Kim Yun-mi 2020-05-22 17:29
Chinese regulator OKs Genexine's P2 trial of glioblastoma treatment by Lee Han-soo 2020-05-22 17:23
JW Pharma launches long-lasting hydraulic acid filler by Lee Han-soo 2020-05-22 16:20
‘No reckless interpretations of Moderna’s Covid-19 vaccine results’   by Kim Yun-mi 2020-05-22 15:27
Alvogen’s obesity drug threatens Novo Nordisk's stronghold in Korea by Lee Han-soo 2020-05-22 15:19
Alvogen Korea to market Luye Pharma’s schizophrenia treatment by Lee Han-soo 2020-05-21 17:02
[Exclusive] Thailand recalls Medytox’s botulinum toxin by Jeong Sae-im 2020-05-21 12:33
SK’s offshoot picked as major raw material supplier to US by Shim Hyun-tai 2020-05-20 18:32
Eisai Korea expands indication for epilepsy treatment by Lee Han-soo 2020-05-20 17:11
Hungary OKs Aptabio's P2 trial for diabetic nephropathy treatment by Lee Han-soo 2020-05-20 15:41
Drugmakers brief development progress of Covid-19 treatments at ‘Bio Korea 2020’ by Shim Hyun-tai 2020-05-19 17:54
ISU Abxis releases preclinical trial results for anticancer antibody by Lee Han-soo 2020-05-18 15:19
SK Bioscience gets Gates Foundation's fund to develop Covid-19 vaccine by Lee Han-soo 2020-05-18 14:53
GC Pharma to supply Covid-19 treatment for free by Lee Han-soo 2020-05-18 11:36
Medytox’s earnings plummet amid lawsuit against Daewoong by Jeong Sae-im 2020-05-18 11:33
‘Many shareholders suffered from Medytox’s public notice of false information’ by Shim Hyun-tai 2020-05-15 17:40
[News Focus] Will Sanofi’s abrupt drop of diabetes study hurt commercial value of Hanmi drug? by Jeong Sae-im 2020-05-15 13:14
‘Lynparza extended survival of ovarian cancer patients’ by Kim Yun-mi 2020-05-14 15:14
Back to Top